#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Vascular calcification Autoimmune myositis Synovial sarcoma recurrent Astrocytoma malignant Follicle centre lymphoma follicular grade I II – III refractory Neuroblastoma Adult T-cell lymphoma/leukaemia refractory Thermal burn Adenocarcinoma pancreas Hereditary optic atrophy Chronic graft versus host disease in intestine Chronic myelomonocytic leukaemia Retinal artery occlusion Hepatitis B Haemophilia More trials…

    Learn about Rare Diseases

    Leiomyosarcoma metastatic – Trials in Disease Shprintzen-Goldberg syndrome – Treatment Congenital hypotransferrinaemia Haemophagocytic lymphohistiocytosis – Trials in Disease Hairy cell leukaemia recurrent – Basic Information Langerhans cell sarcoma – Life with Disease Leiomyosarcoma – Life with Disease Pituitary-dependent Cushing’s syndrome – Life with Disease Lymphangiosarcoma – Trials in Disease Hereditary angioedema with C1 esterase inhibitor deficiency – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Afamitresgene Autoleucel Lavender Oil Flupentixol Decanoate VOROLANIB Bilastine [18F]Fapi-74 Protein S Pilocarpine Nitrate Glepaglutide Lib-01 Monohydrate TROFOLASTAT Azd0305 Fadraciclib Obexelimab Ociperlimab Verapamil Galunisertib Finasteride Satralizumab Vamorolone More therapies…

    Learn about Your Condition

    Glanzmann's disease Bladder cancer Eyelid ptosis Muscle hypertrophy Double hit lymphoma Ovarian granulosa cell tumour Psychogenic seizure Liposarcoma metastatic Autoimmune hepatitis Skin bacterial infection Behcet's syndrome Multiple system atrophy Castleman's disease Blood iron increased Idiopathic pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Effect of sodium hydrogen carbonate on kidney health in critically ill patients with metabolic acidosis and acute kidney injury

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • MAGNESIUM ACETATE TETRAHYDRATE
    • Magnesium Chloride Hexahydrate
    • Sodium Acetate Trihydrate
    Germany

  • A study of emavusertib and zanubrutinib in patients with chronic lymphocytic leukemia and other B-cell cancers.

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Emavusertib
    • Zanubrutinib
    Italy Spain

  • Using glucagon and automated insulin delivery to prevent low blood sugar during exercise in adults with type 1 diabetes

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Type 1 diabetes mellitus
    Investigated Drugs:
    • Glucagon
    • Dasiglucagon
    Denmark

  • A study of ulixertinib, tovorafenib, and vinblastine sulfate for children with progressive, relapsed, or refractory low-grade glioma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Glioma
    Investigated Drugs:
    • Tovorafenib
    • Vinblastine Sulfate
    • ULIXERTINIB
    Austria Czechia Denmark Germany Sweden

  • A study to evaluate the effect of zigakibart in adults with IgA nephropathy

    Recruiting

    2 1 1
    Investigated Drugs:
    • ZIGAKIBART
    Czechia Germany Italy Poland Spain

  • A study to evaluate the long-term safety and effectiveness of BMN 351 in patients with Duchenne muscular dystrophy amenable to exon 51 skipping.

    Recruiting

    2 1 1
    Italy The Netherlands Spain
Previous Page
1 … 43 44 45 46 47 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!